2016
DOI: 10.1007/s10719-016-9706-y
|View full text |Cite
|
Sign up to set email alerts
|

Glycosphingolipids of human embryonic stem cells

Abstract: The application of human stem cell technology offers theoretically a great potential to treat various human diseases. However, to achieve this goal a large number of scientific issues remain to be solved. Cell surface carbohydrate antigens are involved in a number of biomedical phenomena that are important in clinical applications of stem cells, such as cell differentiation and immune reactivity. Due to their cell surface localization, carbohydrate epitopes are ideally suited for characterization of human plur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
17
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(19 citation statements)
references
References 61 publications
2
17
0
Order By: Relevance
“…Gangliosides with multiple sialylation such as GT1, GD3, GD2 and GD1 also increased in neural cells. The shift in the neural glycomic profile toward a greater abundance and density of sialic acids is in good agreement with published literature, albeit on other cell lines ( Park et al 2015 ; Breimer et al 2017 ).…”
Section: Resultssupporting
confidence: 91%
See 1 more Smart Citation
“…Gangliosides with multiple sialylation such as GT1, GD3, GD2 and GD1 also increased in neural cells. The shift in the neural glycomic profile toward a greater abundance and density of sialic acids is in good agreement with published literature, albeit on other cell lines ( Park et al 2015 ; Breimer et al 2017 ).…”
Section: Resultssupporting
confidence: 91%
“…Differentiation can also alter the glycomic landscape on the cell surface, reflecting the evolution in the functions of the cell ( Hakomori 1981 ; Lau et al 2007 ). Pluripotency is linked to the increased expression of N -glycan high mannose structures ( Hasehira et al 2012 ) and globo-type glycosphingolipid (GSL) structures, particularly stage-specific embryonic antigens (SSEA), which are regarded as markers for cell pluripotency ( Breimer et al 2017 ). When differentiated into neural progenitors, GSL expression is shifted from globo- and lacto-type structures to sialylated gangliosides ( Liang et al 2011 ).…”
Section: Introductionmentioning
confidence: 99%
“…Both the H-type 1 and Globo H antigens are present on pluripotent cells and can be used as glyco-markers. The Globo H glycosphingolipid is also highly expressed on malignant tissues, particularly in breast and small cell lung cancers [24,25]. Globo H presents the H-type 3 antigen (Fucα1-2Galβ1-3GalNAc) which only differs from H-type 1 antigen (Fucα1-2Galβ 1-3GlcNAc) by the epimerization of GlcNAc at C4 position.…”
Section: Discussionmentioning
confidence: 99%
“…ectoderm, mesoderm and endoderm) (Liang et al, 2010(Liang et al, , 2011Russo et al, 2018) (Table S1). Pluripotent stem cells express GSLs of the globo and lacto series (Breimer et al, 2017;Liang et al, 2010Liang et al, , 2011Russo et al, 2018), including Gb3, Gb4, Gb5 (SSEA-3), α1-2 fucosylated-Gb5 (Globo H), sialyl-Gb5 (SSEA-4) and disialyl-Gb5, globo-A, Lc3, Lc4, SSEA-1 and fucosyl-Lc4 (Breimer et al, 2017) (Fig. 3).…”
Section: Gsl Reprograming In Development Cell Differentiation and Camentioning
confidence: 99%